Get the Stockscreener App
7.12
3.39%
-0.25
After Hours:
7.12
Day One Biopharmaceuticals Inc stock is traded at $7.12, with a volume of 671.27K.
It is down -3.39% in the last 24 hours and up +15.96% over the past month.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
See More
Previous Close:
$7.37
Open:
$7.38
24h Volume:
671.27K
Relative Volume:
0.45
Market Cap:
$729.32M
Revenue:
$187.64M
Net Income/Loss:
$-95.00M
P/E Ratio:
-7.4947
EPS:
-0.95
Net Cash Flow:
$-69.02M
1W Performance:
-5.70%
1M Performance:
+15.96%
6M Performance:
-19.00%
1Y Performance:
-47.92%
1-Day Range:
$7.03
$7.38
1-Week Range:
$7.03
$7.55
52-Week Range:
$5.635
$16.76
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
Name
Day One Biopharmaceuticals Inc
Sector
Industry
Phone
650 484-0899
Address
2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
Compare DAWN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
7.12 | 743.66M | 187.64M | -95.00M | -69.02M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-25 | Initiated | Piper Sandler | Overweight |
| Oct-09-24 | Reiterated | Needham | Buy |
| Aug-01-24 | Upgrade | BofA Securities | Underperform → Buy |
| Apr-24-24 | Reiterated | Needham | Buy |
| Apr-25-23 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-08-23 | Initiated | CapitalOne | Overweight |
| Feb-03-23 | Initiated | Oppenheimer | Perform |
| Dec-15-22 | Initiated | H.C. Wainwright | Buy |
| Dec-14-22 | Initiated | Needham | Buy |
| Dec-05-22 | Initiated | Goldman | Buy |
| Dec-01-22 | Initiated | BofA Securities | Buy |
View All
Day One Biopharmaceuticals Inc Stock (DAWN) Latest News
Parkman Healthcare Partners LLC Buys 42,688 Shares of Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Trexquant Investment LP Purchases 116,810 Shares of Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Ieq Capital LLC Acquires New Holdings in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Estuary Capital Management LP Has $26.38 Million Stock Holdings in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Alyeska Investment Group L.P. Boosts Stock Holdings in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Bollinger Bands Show Potential Breakout in Day One Biopharmaceuticals Inc.Bear Alert & Capital Efficiency Focused Strategies - beatles.ru
Piper Sandler Starts Coverage on Day One (DAWN) with Overweight Rating - MSN
Day One Biopharmaceuticals Inc. Recovers — But Is It SustainableJuly 2025 Macro Moves & AI Enhanced Market Trend Forecasts - beatles.ru
Top 10 Stocks Under $10 That Could Triple - Insider Monkey
JonesTrading Maintains Buy Rating on Day One Biopharmaceuticals (DAWN) Following Ojemda’s FDA Approval - MSN
Vestal Point Capital LP Acquires 1,158,127 Shares of Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
139,658 Shares in Day One Biopharmaceuticals, Inc. $DAWN Bought by Nuveen LLC - MarketBeat
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Held Back By Insufficient Growth Even After Shares Climb 30% - simplywall.st
Day One Biopharmaceuticals, Inc. $DAWN Shares Sold by Braidwell LP - MarketBeat
Aug Rallies: Is Day One Biopharmaceuticals Inc. stock a good pick for beginnersEarnings Overview Report & Safe Entry Trade Reports - خودرو بانک
What is Day One Biopharmaceuticals Inc. s P E ratio telling usWeekly Gains Summary & Intraday High Probability Setup Alerts - خودرو بانک
Is Day One Biopharmaceuticals Inc. stock a good pick for beginnersQuarterly Performance Summary & Weekly High Return Opportunities - خودرو بانک
Is Day One Biopharmaceuticals Inc. still worth holding after the dipJuly 2025 Intraday Action & AI Enhanced Execution Alerts - Newser
Will Day One Biopharmaceuticals Inc. stock go up in YEARJuly 2025 Spike Watch & Fast Entry and Exit Trade Plans - خودرو بانک
What earnings revisions data tells us about Day One Biopharmaceuticals Inc.Market Risk Report & Reliable Trade Execution Plans - Newser
What MACD and RSI say about Day One Biopharmaceuticals Inc.Market Trend Report & Reliable Intraday Trade Plans - Newser
Is Day One Biopharmaceuticals Inc. affected by consumer sentimentWeekly Gains Report & Risk Managed Investment Strategies - خودرو بانک
How to build a dashboard for Day One Biopharmaceuticals Inc. stockJuly 2025 Volume & High Accuracy Swing Entry Alerts - Newser
Why is Day One Biopharmaceuticals Inc. stock going downJuly 2025 Analyst Calls & Weekly High Return Opportunities - خودرو بانک
What’s the fair value of Day One Biopharmaceuticals Inc. stockEarnings Trend Report & Low Risk High Reward Ideas - خودرو بانک
Can you recover from losses in Day One Biopharmaceuticals Inc.Quarterly Risk Review & Daily Chart Pattern Signal Reports - Newser
Is Day One Biopharmaceuticals Inc. undervalued by DCF analysis2025 Major Catalysts & Long-Term Growth Plans - خودرو بانک
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Heatmap analysis for Day One Biopharmaceuticals Inc. and competitorsWeekly Trend Summary & Daily Volume Surge Signals - Newser
Exit Recap: Is Day One Biopharmaceuticals Inc. stock a good pick for beginners2025 Valuation Update & Precise Trade Entry Recommendations - خودرو بانک
Analyzing net buyer seller activity in Day One Biopharmaceuticals Inc.July 2025 Trade Ideas & Technical Entry and Exit Alerts - Newser
Identifying reversal signals in Day One Biopharmaceuticals Inc.2025 EndofYear Setup & AI Enhanced Execution Alerts - Newser
Is Day One Biopharmaceuticals Inc.’s growth already priced inJobs Report & High Accuracy Swing Trade Signals - خودرو بانک
Recovery Setup Building in Day One Biopharmaceuticals Inc. Experts SayTrend Reversal & Low Risk High Reward Trade Ideas - beatles.ru
Does Day One Biopharmaceuticals Inc. qualify in momentum factor screeningCEO Change & Free Community Consensus Stock Picks - Newser
Real time breakdown of Day One Biopharmaceuticals Inc. stock performanceTrade Ideas & Technical Pattern Based Signals - Newser
What are Day One Biopharmaceuticals Inc.’s technical support levelsTrade Volume Summary & Smart Swing Trading Alerts - خودرو بانک
What is the dividend yield of Day One Biopharmaceuticals Inc.2025 Stock Rankings & Risk Managed Investment Signals - خودرو بانک
Is Day One Biopharmaceuticals Inc. reversing from oversold territoryJuly 2025 Big Picture & AI Enhanced Trading Alerts - Newser
Reversal indicators forming on Day One Biopharmaceuticals Inc. stock2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
Can swing trading help recover from Day One Biopharmaceuticals Inc. losses - Newser
Sentiment analysis tools applied to Day One Biopharmaceuticals Inc.Weekly Trade Analysis & AI Enhanced Market Trend Forecasts - Newser
Update Recap: What is the dividend yield of Day One Biopharmaceuticals Inc.2025 Stock Rankings & Risk Managed Investment Signals - خودرو بانک
Is Day One Biopharmaceuticals Inc. stock a good dividend stockQuarterly Earnings Report & Smart Allocation Stock Reports - خودرو بانک
Is this a good reentry point in Day One Biopharmaceuticals Inc.Rate Cut & Daily Profit Maximizing Trade Tips - Newser
Day One Biopharmaceuticals Inc. stock daily chart insightsEarnings Risk Summary & Community Consensus Picks - Newser
Day One Biopharmaceuticals Inc Stock (DAWN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):